SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave ($CRWV) is trending downwards due to lowered revenue guidance attributed to supply chain delays, sparking concerns despite strong AI-driven demand and a substantial backlog. Community discussions revolve around the severity of the delay's impact and comparisons to competitors, with some investors expressing long-term confidence while others weigh the risks amid broader AI sector volatility. Analyst downgrades and insider selling are adding to the negative sentiment.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto Inc. is experiencing significant upward momentum, triggering community discussion around a potential short squeeze. This follows news of the company's acquisition of Damora Therapeutics and a substantial private placement. Traders are closely watching for continuation patterns and potential price targets, with some highlighting the stock's low float and high short interest as catalysts for further gains.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending due to speculation of a potential short squeeze, supported by bullish technical indicators. Community members are pointing to warrant distributions and reported insider buying as potential catalysts. Some traders are also excited about the company's new CEO and AI-driven turnaround strategy.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors closely monitor discussions surrounding its Alzheimer's drug, Blarcamesine, with community debates focusing on potential approval outcomes and the significance of an oral explanation from the EMA. Concerns over market manipulation and short selling are prevalent, while some investors express confidence based on the drug's safety profile and potential benefits, leading to speculation about a possible short squeeze.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to CEO Lisa Su's optimistic long-term financial outlook presented at the company's analyst day, including projections of significant revenue growth and a $1 trillion data center market by 2030. The community is buzzing about AMD's potential to capture a larger share of the AI data center market, comparing it to Nvidia's dominance.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending due to recent dilution news and a $3 billion Meta AI infrastructure deal, leading to mixed community sentiment. While some investors express concerns about short-term impacts and potential overvaluation, others emphasize the long-term growth potential and strong partnerships with major tech companies. The community is actively debating the significance of the dilution and its effect on future stock performance.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as the community discusses its potential for acquisition amidst a bidding war for a competitor, Metsera. Community members speculate on which pharmaceutical company will acquire Viking, with some suggesting a non-pharma player could emerge. The excitement is fueled by positive clinical data and the increasing importance of obesity and NASH assets in the market.

Waton Financial Ltd. is a holding company, which engages in the provision of securities brokerage and financial technology services. It is also involved in software licensing and related support services including the licensing of trading platform app, upgrades and enhancements, maintenance, and other related services to financial institutions. The company was founded on June 25, 2010 and is headquartered in Hong Kong.

Waton Financial Ltd.

Waton Financial Ltd

Waton Financial ($WTF) is trending primarily due to community interest in its ticker symbol and speculation around its potential in AI and Web3. Recent news highlights the company's launch of an AI trading system and expansion into digital assets, sparking discussions about its fintech strategy. The community is closely watching for significant price movement and potential breakouts.

enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.

enGene Holdings Inc

ENGN is trending due to positive data from its bladder cancer study, with the community actively discussing its potential for a short squeeze given the high cost to borrow and low float. Some traders are setting stop losses and sell orders, while others believe institutional investment signals a potential reprice. Analyst upgrades and the potential for a significant price increase are also fueling interest.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending as investors anticipate upcoming catalysts, including a presentation at the NYC Skin Disease Summit and upcoming earnings. The community is discussing the potential for positive data readouts to drive a significant price increase, with some speculating on a potential acquisition. Bullish sentiment is fueled by institutional ownership and recent insider buying.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


1win_PLAY

SomvozRu